SPRYCEL® (dasatinib) - Official Patient Website
SPRYCEL® (dasatinib) is used to treat adults and children 1 year of age and older with newly diagnosed Ph+ CML (Philadelphia chromosome-positive chronic myeloid leukemia) in chronic phase.
SPRYCEL® Treatment for Ph+ CML in Adults - SPRYCEL® (dasatinib)
Learn more about SPRYCEL® (dasatinib) treatment for Ph+ CML (Philadelphia chromosome-positive chronic myeloid leukemia) in chronic phase in adults. Please see Indication and Important Safety …
SPRYCEL for Ph+ CML in Children - SPRYCEL® (dasatinib)
Learn more about SPRYCEL® (dasatinib) treatment for Ph+ CML (Philadelphia chromosome-positive chronic myeloid leukemia) in chronic phase in children 1 year of age or older.
SPRYCEL was approved for this condition based on a clinical trial comparing SPRYCEL to another treatment (imatinib). The goals of the study were to look at certain results and report on side effects. …
Get more involved in your treatment The more you learn about your treatment and test results, the more productive your discussions with the team will be. • Visit SPRYCEL.com for helpful information and …
e considering treatment with SPRYCEL. Here are some of the questions you may want to ask your doc Asking questions can help you learn more about your treatment and what you can expect. You may …
301 Moved Permanently
Moved Permanently The document has moved here.